-
Rodman & Renshaw Starts Beyond Air (XAIR) at Buy
-
XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
-
XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
-
Beyond Air expands LungFit PH distribution to 39 countries
-
Beyond Air, Inc. (XAIR) files for 1.6M share offering by selling stockholders
-
Beyond Air, Inc. (XAIR) Misses Q2 EPS by 116c
-
Beyond Air secures $32 million financing from Streeterville Capital
-
Beyond Air raises $3.25 million through warrant exercise agreement
-
NeuroNOS receives FDA orphan drug designation for glioblastoma treatment
-
Beyond Air expands LungFit PH distribution to Japan and five other countries
-
Beyond Air (XAIR) PT Lowered to $5 at Piper Sandler
-
Beyond Air, Inc. (XAIR) Misses Q1 EPS by 43c
-
Beyond Air wins Premier group purchasing agreement for therapeutic gases
-
D. Boral Capital Starts Beyond Air (xair) at Buy
-
Beyond Air, Inc. (XAIR) Tops Q4 EPS by 6c, Misses on Revenue
-
Beyond Air's (XAIR) NeuroNOS receives FDA orphan drug designation for BA-102
-
Beyond Air, Inc. (XAIR) subsidiary NeuroNOS appoints Dan Shechtman to SAB
-
Beyond Air, Inc. (XAIR) Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Di
-
Beyond Air, Inc. (XAIR) Announces Agreements Expanding Global Distribution of LungFit PH
-
BTIG Reiterates Neutral Rating on Beyond Air (XAIR)
-
Beyond Air, Inc. (XAIR) Reports In-Line Q3 EPS, Beats on Revenue
-
Beyond Air, Inc. (XAIR) granted extension by Nasdaq to regain compliance with minimum bid price
-
Jones Trading Starts Beyond Air (XAIR) at Buy
-
Beyond Air, Inc. (XAIR) Announces LungFit PH Receives Market Authorization in Australia
-
Beyond Air, Inc. (XAIR) Receives CE Mark in Europe for the LungFit PH System
-
Piper Sandler Reiterates Overweight Rating on Beyond Air (XAIR)
-
Beyond Air, Inc. (XAIR) Reports In-Line Q2 EPS
-
Beyond Air, Inc. (XAIR) Files for 81.7M Share Offering by Selling Stockholders
-
Beyond Air (XAIR) Partners with Healthcare Links to Expand Access to LungFit PH System Through Group Purchasing Organizations and Integrated Delivery Networks
-
Beyond Air, Inc. (XAIR) Provides LungFit PH System to U.S. Naval Hospital Guam
-
Beyond Air, Inc. (XAIR) Announces Termination of the Loan and Security Agreements with Avenue Capital
-
Beyond Air, Inc. (XAIR) Announces $20.6M Share Offering
-
Roth/MKM Resumes Beyond Air (XAIR) at Buy
-
Beyond Air (XAIR) PT Lowered to $1 at Piper Sandler
-
Beyond Air, Inc. (XAIR) Tops Q1 EPS by 7c
-
BTIG Downgrades Beyond Air (XAIR) to Neutral
-
Beyond Air, Inc. (XAIR) Misses Q4 EPS by 133c
-
Beyond Air (XAIR) Appoints David Webster as Chief Commercial Officer

